Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system-Reference-Cited by-同舟云学术

Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system

Published:2001-06 Issue:6 Volume:1 Page:1123-1130
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Hedlund Gunnar,Link Hans,Zhu Jie,Xiao Bao-Guo

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference65 articles.

1. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator;Kalland;J. Immunol.,1985

2. Effects of the novel immunomodulator LS 2616 on the delayed-type hypersensitivity reaction to Bordetella pertussis in the rat;Stålhandske;Immunopharmacology,1986

3. Mechanism of action of the new immunomodulator LS2616 on T cell responses;Larsson;Int. J. Immunopharmacol.,1987

4. Abolition of the effect of cyclosporine on rat cardiac allograft rejection by the new immunomodulator LS-2616 (Linomide);Wanders;Transplantation,1989

5. Regulation of natural killer progenitors: studies with a novel immunomodulator with distinct effects at the precursor level;Kalland;J. Immunol.,1990

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitory Effect of Paquinimod on a Murine Model of Neutrophilic Asthma Induced by Ovalbumin with Complete Freund’s Adjuvant;Canadian Respiratory Journal;2021-03-15

2. Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer’s Disease: Are Immunotherapies Effective or Off-Target?;The Neuroscientist;2021-02-03

3. Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse;PLOS ONE;2018-05-09

4. Synthesis of Dissymmetric Malonic Acid Monoamides from Symmetric Dithiomalonates;ChemistrySelect;2016-12-16

5. Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in;Arthritis & Rheumatism;2012-04-26